The authors reply

Affiliations

¹ Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
² Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Free article

Comment

Dick de Zeeuw et al. Kidney Int. 2014 Dec.

Free article

. 2014 Dec;86(6):1270.

doi: 10.1038/ki.2014.263.

¹ Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
² Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

No abstract available

Comment on

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.
Molitch ME, Adler AI, Flyvbjerg A, Nelson RG, So WY, Wanner C, Kasiske BL, Wheeler DC, de Zeeuw D, Mogensen CE. Molitch ME, et al. Kidney Int. 2015 Jan;87(1):20-30. doi: 10.1038/ki.2014.128. Epub 2014 Apr 30. Kidney Int. 2015. PMID: 24786708 Free PMC article.
ACE-I vs. ARB for blood pressure control in diabetic kidney disease.
Tonneijck L, Muskiet MH, van Raalte DH. Tonneijck L, et al. Kidney Int. 2014 Dec;86(6):1270. doi: 10.1038/ki.2014.262. Kidney Int. 2014. PMID: 25427090 No abstract available.